SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017506
Filing Date
2019-11-14
Accepted
2019-11-14 16:31:51
Documents
65
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 540644
2 ex31-1.htm EX-31.1 18875
3 ex31-2.htm EX-31.2 17292
4 ex32-1.htm EX-32.1 7199
5 ex32-2.htm EX-32.2 7018
  Complete submission text file 0001493152-19-017506.txt   4194034

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aim-20190930.xml EX-101.INS 730954
7 XBRL SCHEMA FILE aim-20190930.xsd EX-101.SCH 68307
8 XBRL CALCULATION FILE aim-20190930_cal.xml EX-101.CAL 61511
9 XBRL DEFINITION FILE aim-20190930_def.xml EX-101.DEF 215649
10 XBRL LABEL FILE aim-20190930_lab.xml EX-101.LAB 429949
11 XBRL PRESENTATION FILE aim-20190930_pre.xml EX-101.PRE 279392
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 191220907
SIC: 2836 Biological Products, (No Diagnostic Substances)